Literature DB >> 16423606

Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome.

Ellen M N Bannink1, Hein Raat, Paul G H Mulder, Sabine M P F de Muinck Keizer-Schrama.   

Abstract

OBJECTIVE: To evaluate health-related quality of life (HRQoL) in young women with Turner syndrome (TS) after long-term growth hormone (GH) therapy and induced puberty and to analyze whether HRQoL was influenced by auxologic parameters, pubertal development, or subjective parameters. STUDY
DESIGN: The study group comprised 49 women with TS, mean (standard deviation) age 19.6 (+/-3.0) years, all former participants of 2 GH studies, > or =6 months after GH discontinuation. Puberty was induced by estrogen treatment, at mean age 12.9 (+/-1.1) years. HRQoL was measured by self-reports of the 2 generic questionnaires, SF36 and TAAQOL. As an additional source of information on HRQoL, we applied parental proxy reports.
RESULTS: HRQoL of the women with TS was normal. Remarkably, the women with TS had higher HRQoL scores on some of the scales, including "social functioning" and "role-emotional." Satisfaction with height and breast development had a positive influence on several HRQoL scales.
CONCLUSIONS: The young women with TS who reached normal height and had age-appropriate pubertal development reported normal HRQoL. The relatively high scores on some of the HRQoL scales can be explained by an estrogen effect or by a possible response shift, indicating a different internal reference in women with TS. We hypothesize that GH and estrogen treatment positively influenced HRQoL in young women with TS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423606     DOI: 10.1016/j.jpeds.2005.08.043

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Systematic review of quality of life in Turner syndrome.

Authors:  Carolina Trombeta Reis; Maíra Seabra de Assumpção; Gil Guerra-Junior; Sofia Helena Valente de Lemos-Marini
Journal:  Qual Life Res       Date:  2018-02-09       Impact factor: 4.147

2.  Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone.

Authors:  Shayne P Taback; Guy Van Vliet
Journal:  BMC Pediatr       Date:  2011-05-29       Impact factor: 2.125

Review 3.  Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis.

Authors:  Dahima Cintron; Rene Rodriguez-Gutierrez; Valentina Serrano; Paula Latortue-Albino; Patricia J Erwin; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

4.  The Generation R study: a candidate gene study and genome-wide association study (GWAS) on health-related quality of life (HRQOL) of mothers and young children.

Authors:  Hein Raat; Lenie van Rossem; Vincent W V Jaddoe; Jeanne M Landgraf; David Feeny; Henriëtte A Moll; Albert Hofman; Johan P Mackenbach
Journal:  Qual Life Res       Date:  2010-10-28       Impact factor: 4.147

5.  The influence of psychosocial and sexual wellbeing on quality of life in women with differences of sexual development.

Authors:  Ariane Liedmeier; David Jendryczko; Marion Rapp; Robert Roehle; Ute Thyen; Baudewijntje P C Kreukels
Journal:  Compr Psychoneuroendocrinol       Date:  2021-09-24

6.  Psychosocial Characteristics of Women with a Delayed Diagnosis of Turner Syndrome.

Authors:  Gabrielle E Reimann; Martha M Bernad Perman; Pei-Shu Ho; Rebecca A Parks; Leora E Comis
Journal:  J Pediatr       Date:  2018-05-09       Impact factor: 4.406

7.  Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood.

Authors:  Grit Sommer; Micol E Gianinazzi; Rahel Kuonen; Julia Bohlius; Dagmar l'Allemand; Michael Hauschild; Primus-Eugen Mullis; Claudia E Kuehni
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 8.  Diagnostic and therapeutic considerations in Turner syndrome.

Authors:  Seung Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

9.  Recombinant human growth hormone in the treatment of Turner syndrome.

Authors:  Bessie E Spiliotis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

10.  Effects of Psychosomatic Mutual Aid Treatment on Anxiety and Depression in Turner Syndrome.

Authors:  Mudan Ye; Huijia Lin; Gendie E Lash; Lianxiong Yuan; Li Li
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.